Lloyds Banking Group plc has purchased 7,127,731 ordinary shares on 19 February 2026 through Goldman Sachs International as part of its ongoing share buyback programme. The volume weighted average price paid per share was 102.8627 pence, with the highest price at 105.1500 pence and the lowest at 101.8000 pence. These repurchased shares are intended for cancellation, which typically signals a positive move for shareholders by reducing the number of outstanding shares and potentially increasing earnings per share.
Lloyds Banking Group plc (the "Company") announces today that it has purchased the following number of its ordinary shares, from Goldman Sachs International (the "Broker").
Ordinary Shares
Date of purchases: 19 February 2026
Number of ordinary shares purchased: 7,127,731
Highest price paid per share (pence): 105.1500
Lowest price paid per share (pence): 101.8000
Volume weighted average price paid per share (pence): 102.8627
Such purchases form part of the Company's existing share buyback programme and were effected pursuant to the instructions issued to the Broker by the Company on 29 January 2026, as announced on 30 January 2026.
The Company intends to cancel these shares.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as such legislation forms part of assimilated law as defined in the EU (Withdrawal) Act 2018), a full breakdown of the individual trades made by the Broker on behalf of the Company as part of the buyback programme is set out in the Schedule to this announcement available through the link below:
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may contain inaccuracies, outdated information, or subjective interpretations. This content is intended for general informational purposes only and should not be considered professional advice or factual confirmation.
We encourage you to independently verify any information provided, especially if it will be relied upon for making decisions or taking action. Any reliance you place on this material is strictly at your own risk. The AI system that produced this content cannot assess the specifics of individual circumstances, and results may vary based on context and individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
